News

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Arrowhead Pharmaceuticals Inc (Symbol: ARWR), where a total of 9,321 contracts have traded so far, representing approximately 932,100 underlying shares. That amounts to about 55.5% of ARWR's average daily trading volume over the past month of 1.7 million shares. Particularly high volume was seen for the $30 strike call option expiring March 15, 2024, with 4,169 contracts trading so far today, representing approximately 416,900 underlying shares of ARWR. Below is a chart showing ARWR's trailing twelve month trading history, with the $30 strike highlighted in orange:

Roblox Corp (Symbol: RBLX) saw options trading volume of 38,223 contracts, representing approximately 3.8 million underlying shares or approximately 53% of RBLX's average daily trading volume over the past month, of 7.2 million shares. Particularly high volume was seen for the $45 strike call option expiring April 19, 2024, with 5,337 contracts trading so far today, representing approximately 533,700 underlying shares of RBLX. Below is a chart showing RBLX's trailing twelve month trading history, with the $45 strike highlighted in orange:

And Moderna Inc (Symbol: MRNA) options are showing a volume of 24,146 contracts thus far today. That number of contracts represents approximately 2.4 million underlying shares, working out to a sizeable 53% of MRNA's average daily trading volume over the past month, of 4.6 million shares. Particularly high volume was seen for the $105 strike call option expiring March 15, 2024, with 919 contracts trading so far today, representing approximately 91,900 underlying shares of MRNA. Below is a chart showing MRNA's trailing twelve month trading history, with the $105 strike highlighted in orange:

For the various different available expirations for ARWR options, RBLX options, or MRNA options, visit StockOptionsChannel.com.

Also see:

VSEC Historical Stock Prices
SPIP Dividend History
Funds Holding LACO

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.